Chemotherapy, post-adjuvant therapy, and clinical trial ethics at St Gallen BCC 2023

The St Gallen Breast Cancer Congress took place on the 15-18 March 2023. Leading researchers and experts were brought together in Vienna, Austria, to discuss and debate the most important updates in breast cancer. In this podcast, we’ll run through research updates spanning from early treatment to post-adjuvant therapy and a taste of the ethical considerations involved in recruiting for clinical trials. We’ll be hearing from Prof. Philip Poortmans of AZ Sint-Augustinus – Oncologisch Centrum GZA, Dr Lisa Carey of UNC Lineberger Comprehensive Cancer Center, Dr Marleen Kok of the Netherlands Cancer Institute, Dr Hope S. Rugo of Helen Diller Family Comprehensive Cancer Center, Dr Sara Tolaney of Dana-Farber Cancer Institute, and Dr Orit Kaidar-Person of Sheba Medical Center, about new developments in our understanding of appropriate chemotherapy and immunotherapy options, as well as the importance of this conference in progressing clinical practice for breast cancer.

The post Chemotherapy, post-adjuvant therapy, and clinical trial ethics at St Gallen BCC 2023 appeared first on VJOncology.